No decrease in CD4/CD8 ratio after 36 months therapy in patients switched to dual regimens containing rilpivirine - Tortajada C; Castellano L; Mengual A; Flores J (ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2021)